PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12829525-0	2003	Reduced expression of endothelial connexin37 and connexin40 in hyperlipidemic mice: recovery of connexin37 after 7-day simvastatin treatment.	Simvastatin	119-130	gap junction protein, alpha 4	Mus musculus	96-106	
12829525-8	2003	Short-term treatment with simvastatin leads to recovery of Cx37 expression but not Cx40 expression.	Simvastatin	26-37	gap junction protein, alpha 4	Mus musculus	59-63	
22659288-11	2012	Moreover after exposure to simvastatin, a well-known KLF2 inducer, KLF2 binds to the Cx37 promoter region as shown by ChIP.	Simvastatin	27-38	gap junction protein, alpha 4	Mus musculus	85-89	
18443364-6	2008	Western blotting of aortae showed reduced expression of connexin37 (Cx37) and Cx40 in the diabetic mice, which were further decreased in the simvastatin-treated diabetic mice.	Simvastatin	141-152	gap junction protein, alpha 4	Mus musculus	56-66	
18443364-6	2008	Western blotting of aortae showed reduced expression of connexin37 (Cx37) and Cx40 in the diabetic mice, which were further decreased in the simvastatin-treated diabetic mice.	Simvastatin	141-152	gap junction protein, alpha 4	Mus musculus	68-72	
18443364-8	2008	The reduction was greater in the simvastatin-treated mice (decrease in treated diabetic vs non-diabetic: Cx37, 61%; Cx40, 79%; both p<0.01; decrease in treated diabetic vs untreated diabetic: Cx37, 34%; Cx40, 63%; both p<0.01).	Simvastatin	33-44	gap junction protein, alpha 4	Mus musculus	105-109	
18443364-8	2008	The reduction was greater in the simvastatin-treated mice (decrease in treated diabetic vs non-diabetic: Cx37, 61%; Cx40, 79%; both p<0.01; decrease in treated diabetic vs untreated diabetic: Cx37, 34%; Cx40, 63%; both p<0.01).	Simvastatin	33-44	gap junction protein, alpha 4	Mus musculus	195-199